These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 22545737)

  • 1. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial.
    Safren SA; O'Cleirigh CM; Bullis JR; Otto MW; Stein MD; Pollack MH
    J Consult Clin Psychol; 2012 Jun; 80(3):404-15. PubMed ID: 22545737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial.
    Safren SA; Bedoya CA; O'Cleirigh C; Biello KB; Pinkston MM; Stein MD; Traeger L; Kojic E; Robbins GK; Lerner JA; Herman DS; Mimiaga MJ; Mayer KH
    Lancet HIV; 2016 Nov; 3(11):e529-e538. PubMed ID: 27658881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression CBT treatment gains among HIV-infected persons with a history of injection drug use varies as a function of baseline substance use.
    Labbe AK; O'Cleirigh CM; Stein M; Safren SA
    Psychol Health Med; 2015; 20(7):870-7. PubMed ID: 25588153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline Substance Use Interferes with Maintenance of HIV Medication Adherence Skills.
    Dale SK; Traeger L; O'Cleirigh C; Bedoya CA; Pinkston M; Wilner JG; Stein M; Safren SA
    AIDS Patient Care STDS; 2016 May; 30(5):215-20. PubMed ID: 27158849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating depression and improving adherence in HIV care with task-shared cognitive behavioural therapy in Khayelitsha, South Africa: a randomized controlled trial.
    Safren SA; O'Cleirigh C; Andersen LS; Magidson JF; Lee JS; Bainter SA; Musinguzi N; Simoni J; Kagee A; Joska JA
    J Int AIDS Soc; 2021 Oct; 24(10):e25823. PubMed ID: 34708929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals.
    Safren SA; O'Cleirigh C; Tan JY; Raminani SR; Reilly LC; Otto MW; Mayer KH
    Health Psychol; 2009 Jan; 28(1):1-10. PubMed ID: 19210012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Problematic Substance Use Moderate Efficacy of Cognitive Behavioral Therapy for Adherence and Depression in HIV?
    Sanders JN; Glynn TR; Mayo D; Dale SK; Harkness A; Safren SA
    AIDS Behav; 2023 Apr; 27(4):1123-1132. PubMed ID: 36318424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes.
    Safren SA; Gonzalez JS; Wexler DJ; Psaros C; Delahanty LM; Blashill AJ; Margolina AI; Cagliero E
    Diabetes Care; 2014; 37(3):625-33. PubMed ID: 24170758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telephone based cognitive behavioral therapy targeting major depression among urban dwelling, low income people living with HIV/AIDS: results of a randomized controlled trial.
    Himelhoch S; Medoff D; Maxfield J; Dihmes S; Dixon L; Robinson C; Potts W; Mohr DC
    AIDS Behav; 2013 Oct; 17(8):2756-64. PubMed ID: 23644816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising outcomes from a cognitive behavioral therapy text-messaging intervention targeting drug use, antiretroviral therapy adherence, and HIV risk behaviors among adults living with HIV and substance use disorders.
    Glasner S; Patrick K; Ybarra M; Reback CJ; Ang A; Kalichman S; Bachrach K; Garneau HC; Venegas A; Rawson RA
    Drug Alcohol Depend; 2022 Feb; 231():109229. PubMed ID: 34979421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinician-assessed depression and HAART adherence in HIV-infected individuals in methadone maintenance treatment.
    Gonzalez JS; Psaros C; Batchelder A; Applebaum A; Newville H; Safren SA
    Ann Behav Med; 2011 Aug; 42(1):120-6. PubMed ID: 21503833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Initial Open Trial of a Brief Behavioral Activation Treatment for Depression and Medication Adherence in HIV-Infected Patients.
    Tull MT; Berghoff CR; Bardeen JR; Schoenleber M; Konkle-Parker DJ
    Behav Modif; 2018 Mar; 42(2):196-209. PubMed ID: 28799413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment.
    Gonzalez A; Mimiaga MJ; Israel J; Andres Bedoya C; Safren SA
    AIDS Behav; 2013 Jan; 17(1):168-73. PubMed ID: 23008124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of Change in Cognitive Behavioral Therapy for Body Image and Self-Care on ART Adherence Among Sexual Minority Men Living with HIV.
    Lamb KM; Nogg KA; Safren SA; Blashill AJ
    AIDS Behav; 2018 Aug; 22(8):2711-2717. PubMed ID: 29752620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pilot Randomized Control Trial of the Striving Towards EmPowerment and Medication Adherence (STEP-AD) Intervention for Black Women Living with HIV.
    Dale SK; Wright IA; Madhu A; Reid R; Shahid NN; Wright M; Sanders J; Phillips A; Rodriguez A; Safren SA
    AIDS Behav; 2024 Oct; 28(10):3483-3497. PubMed ID: 39012452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating depression and substance use: a randomized controlled trial.
    Hunter SB; Watkins KE; Hepner KA; Paddock SM; Ewing BA; Osilla KC; Perry S
    J Subst Abuse Treat; 2012 Sep; 43(2):137-51. PubMed ID: 22301087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nurse-Delivered Cognitive Behavioral Therapy for Adherence and Depression Among People Living With HIV (the Ziphamandla Study): Protocol for a Randomized Controlled Trial.
    Joska JA; Andersen LS; Smith-Alvarez R; Magidson J; Lee JS; O'Cleirigh C; Safren SA
    JMIR Res Protoc; 2020 Feb; 9(2):e14200. PubMed ID: 32012114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy.
    Springer SA; Chen S; Altice F
    AIDS Care; 2009 Aug; 21(8):976-83. PubMed ID: 20024753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States.
    Dale S; Cohen M; Weber K; Cruise R; Kelso G; Brody L
    AIDS Patient Care STDS; 2014 Mar; 28(3):136-43. PubMed ID: 24568654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief cognitive behavior therapy for stigmatization, depression, quality of life, social support and adherence to treatment among patients with HIV/AIDS: a randomized control trial.
    Abbas Q; Nisa M; Khan MU; Anwar N; Aljhani S; Ramzan Z; Shahzadi M
    BMC Psychiatry; 2023 Jul; 23(1):539. PubMed ID: 37491185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.